Sensible Biotechnologies

Sensible Bio

Sensible Bio develops cell-based biomanufacturing platforms to produce high-quality mRNA for healthcare companies creating next-generation vaccines and therapeutics.

Bitrobius Genetics

This company develops synthetic gene transfer technology for researchers and pharmaceutical firms to manufacture and deliver cell and gene therapies and vaccines.

Etherna

This company develops mRNA and lipid nanoparticle technologies for pharmaceutical and biotechnology partners to create nucleic acid-based medicines and vaccines.

Versameb

This biopharmaceutical company develops mRNA-based therapeutics and technology platforms for protein expression to treat patients with unmet medical needs in various disease areas.

Synthetic biology-powered mRNA therapeutics

The company develops programmable mRNA therapies using synthetic biology genetic circuits to deliver precise treatments for patients with cancer and other complex diseases.

Nuntius Therapeutics

This company develops mRNA and gene-editing therapies using a programmable nanocarrier delivery platform for pharmaceutical companies and research institutions.

Strand Therapeutics

This biotechnology company develops programmable messenger RNA therapies for patients with solid tumours and autoimmune diseases.

Medici Therapeutics

The company develops personalised mRNA cancer vaccines and T cell therapies for patients to treat tumours and combat age-related cellular decline.